{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:39Z","timestamp":1740107019720,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00432-017-2525-0","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T06:35:52Z","timestamp":1506062152000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores"],"prefix":"10.1007","volume":"144","author":[{"given":"Sangjun","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwancheol","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Chul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-1402","authenticated-orcid":false,"given":"Hyeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"issue":"1","key":"2525_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","volume":"69","author":"JO Barentsz","year":"2016","unstructured":"Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69(1):41\u201349. doi:\n                        10.1016\/j.eururo.2015.08.038","journal-title":"Eur Urol"},{"issue":"5","key":"2525_CR2","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.juro.2008.07.051","volume":"180","author":"RK Berglund","year":"2008","unstructured":"Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD (2008) Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 180(5):1964\u20131967. doi:\n                        10.1016\/j.juro.2008.07.051\n                        \n                     (discussion 1967\u20131968)","journal-title":"J Urol"},{"issue":"6","key":"2525_CR3","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.juro.2007.08.039","volume":"178","author":"HB Carter","year":"2007","unstructured":"Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI (2007) Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 178(6):2359\u20132364. doi:\n                        10.1016\/j.juro.2007.08.039\n                        \n                     (discussion 2364\u20132355)","journal-title":"J Urol"},{"issue":"1","key":"2525_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pros.23242","volume":"77","author":"F Castiglione","year":"2017","unstructured":"Castiglione F, Dell\u2019Oglio P, Tosco L, Everaerts W, Albersen M, Hakim L, Van den Broeck T, Moris L, Claessens F, Briganti A, Montorsi F, Van Poppel H, Joniau S (2017) Tumor volume and clinical failure in high-risk prostate cancer patients treated with radical prostatectomy. Prostate 77(1):3\u20139. doi:\n                        10.1002\/pros.23242","journal-title":"Prostate"},{"issue":"5","key":"2525_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.juro.2013.12.006","volume":"191","author":"F Cornud","year":"2014","unstructured":"Cornud F, Khoury G, Bouazza N, Beuvon F, Peyromaure M, Flam T, Zerbib M, Legmann P, Delongchamps NB (2014) Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation? J Urol 191(5):1272\u20131279. doi:\n                        10.1016\/j.juro.2013.12.006","journal-title":"J Urol"},{"issue":"1","key":"2525_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/pcan.2016.51","volume":"20","author":"MA Dall\u2019Era","year":"2017","unstructured":"Dall\u2019Era MA, Klotz L (2017) Active surveillance for intermediate-risk prostate cancer. Prostate Cancer Prostatic Dis 20(1):1\u20136. doi:\n                        10.1038\/pcan.2016.51","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"2525_CR7","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1002\/cncr.23502","volume":"112","author":"MA Dall\u2019Era","year":"2008","unstructured":"Dall\u2019Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR (2008) Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112(12):2664\u20132670. doi:\n                        10.1002\/cncr.23502","journal-title":"Cancer"},{"issue":"6","key":"2525_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","volume":"62","author":"MA Dall\u2019Era","year":"2012","unstructured":"Dall\u2019Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS (2012) Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 62(6):976\u2013983. doi:\n                        10.1016\/j.eururo.2012.05.072","journal-title":"Eur Urol"},{"issue":"6","key":"2525_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.eururo.2005.07.011","volume":"48","author":"A Descazeaud","year":"2005","unstructured":"Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A (2005) What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Eur Urol 48(6):911\u2013915. doi:\n                        10.1016\/j.eururo.2005.07.011","journal-title":"Eur Urol"},{"issue":"3","key":"2525_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.juro.2011.02.2695","volume":"186","author":"JI Epstein","year":"2011","unstructured":"Epstein JI (2011) Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 186(3):790\u2013797. doi:\n                        10.1016\/j.juro.2011.02.2695","journal-title":"J Urol"},{"issue":"2","key":"2525_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/pas.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244\u2013252. doi:\n                        10.1097\/pas.0000000000000530","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2525_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/pcan.2013.61","volume":"17","author":"JJ Knoedler","year":"2014","unstructured":"Knoedler JJ, Karnes RJ, Thompson RH, Rangel LJ, Bergstralh EJ, Boorjian SA (2014) The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 17(2):144\u2013148. doi:\n                        10.1038\/pcan.2013.61","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2525_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00345-016-1861-z","volume":"35","author":"CP Meyer","year":"2017","unstructured":"Meyer CP, Hansen J, Boehm K, Tilki D, Abdollah F, Trinh QD, Fisch M, Sauter G, Graefen M, Huland H, Chun FK, Ahyai SA (2017) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol 35(2):199\u2013206. doi:\n                        10.1007\/s00345-016-1861-z","journal-title":"World J Urol"},{"issue":"4","key":"2525_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, van den Broeck T, van den Poel HG, van den Kwast TH, Rouvi\u00e8re O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618\u2013629. doi:\n                        10.1016\/j.eururo.2016.08.003","journal-title":"Eur Urol"},{"issue":"7","key":"2525_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.10039.x","volume":"108","author":"V Mouraviev","year":"2011","unstructured":"Mouraviev V, Villers A, Bostwick DG, Wheeler TM, Montironi R, Polascik TJ (2011) Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy. BJU Int 108(7):1074\u20131085. doi:\n                        10.1111\/j.1464-410X.2010.10039.x","journal-title":"BJU Int"},{"issue":"1","key":"2525_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1148\/radiol.16151133","volume":"280","author":"SY Park","year":"2016","unstructured":"Park SY, Jung DC, Oh YT, Cho NH, Choi YD, Rha KH, Hong SJ, Han K (2016) Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology 280(1):108\u2013116. doi:\n                        10.1148\/radiol.16151133","journal-title":"Radiology"},{"issue":"3","key":"2525_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cncr.20415","volume":"101","author":"CK Poulos","year":"2004","unstructured":"Poulos CK, Daggy JK, Cheng L (2004) Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Cancer 101(3):527\u2013532. doi:\n                        10.1002\/cncr.20415","journal-title":"Cancer"},{"issue":"2","key":"2525_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","volume":"197","author":"A Priester","year":"2017","unstructured":"Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS (2017) Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol 197(2):320\u2013326. doi:\n                        10.1016\/j.juro.2016.07.084","journal-title":"J Urol"},{"issue":"6b","key":"2525_CR19","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1111\/bju.12637","volume":"114","author":"E Rud","year":"2014","unstructured":"Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbo HB (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32\u2013E42. doi:\n                        10.1111\/bju.12637","journal-title":"BJU Int"},{"issue":"4","key":"2525_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/bju.12938","volume":"115","author":"SS Salami","year":"2015","unstructured":"Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, Villani R, Rastinehad AR (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115(4):562\u2013570. doi:\n                        10.1111\/bju.12938","journal-title":"BJU Int"},{"issue":"2","key":"2525_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1464-410X.2007.07190.x","volume":"101","author":"MS Soloway","year":"2008","unstructured":"Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M (2008) Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 101(2):165\u2013169. doi:\n                        10.1111\/j.1464-410X.2007.07190.x","journal-title":"BJU Int"},{"issue":"28","key":"2525_CR22","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1200\/jco.2005.01.867","volume":"23","author":"AJ Stephenson","year":"2005","unstructured":"Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol Off J Am Soc Clin Oncol 23(28):7005\u20137012. doi:\n                        10.1200\/jco.2005.01.867","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15","key":"2525_CR23","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/pros.23062","volume":"75","author":"F Ting","year":"2015","unstructured":"Ting F, van Leeuwen PJ, Delprado W, Haynes AM, Brenner P, Stricker PD (2015) Tumor volume in insignificant prostate cancer: increasing the threshold is a safe approach to reduce over-treatment. Prostate 75(15):1768\u20131773. doi:\n                        10.1002\/pros.23062","journal-title":"Prostate"},{"issue":"7","key":"2525_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.urolonc.2016.03.005","volume":"34","author":"MD Tyson","year":"2016","unstructured":"Tyson MD, Arora SS, Scarpato KR, Barocas D (2016) Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer. Urol Oncol 34(7):326\u2013332. doi:\n                        10.1016\/j.urolonc.2016.03.005","journal-title":"Urol Oncol"},{"issue":"6","key":"2525_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.eururo.2008.02.039","volume":"54","author":"NJ As van","year":"2008","unstructured":"van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, Horwich A, Dearnaley DP, Parker CC (2008) Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54(6):1297\u20131305. doi:\n                        10.1016\/j.eururo.2008.02.039","journal-title":"Eur Urol"},{"issue":"7","key":"2525_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1464-410X.2009.08887.x","volume":"105","author":"RC Bergh van den","year":"2010","unstructured":"van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schroder FH, Bangma CH (2010) Short-term outcomes of the prospective multicentre \u2018Prostate Cancer Research International: Active Surveillance\u2019 study. BJU Int 105(7):956\u2013962. doi:\n                        10.1111\/j.1464-410X.2009.08887.x","journal-title":"BJU Int"},{"issue":"2","key":"2525_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2013.07.039","volume":"65","author":"O Yossepowitch","year":"2014","unstructured":"Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65(2):303\u2013313. doi:\n                        10.1016\/j.eururo.2013.07.039","journal-title":"Eur Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2525-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2525-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2525-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T03:24:41Z","timestamp":1515209081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2525-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2525-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2017,9,22]]}}}